Art's-Way Manufacturing (ARTW) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 15, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ARTW SEC filings page.
Art's-Way Manufacturing (ARTW) reported $26.0M in revenue over the twelve months to May 31, 2026, up 10.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Art's-Way's dominant mechanic is thin operating profitability paired with volatile cash conversion and a more liquid balance-sheet structure.
By FY2025, revenue had contracted from the prior year while gross margin narrowed to27.3% , showing that weaker activity or mix reached the cost structure rather than being fully absorbed. The gap between net income of$1.0M and operating cash flow of-$904K indicates reported earnings were not translating into cash generated by operations.
The current ratio improved from 2.0x in FY2024 to 2.3x in FY2025, indicating stronger short-term accounting coverage despite the year's cash outflow. Total liabilities were
Inventory stood at
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Art's-Way Manufacturing's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Art's-Way Manufacturing has an operating margin of 1.3%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 43/100, indicating healthy but not exceptional operating efficiency. This is down from 1.9% the prior year.
Art's-Way Manufacturing's revenue declined 6.2% year-over-year, from $24.5M to $23.0M. This contraction results in a growth score of 7/100.
Art's-Way Manufacturing has a moderate D/E ratio of 0.17. This balance of debt and equity financing earns a leverage score of 30/100.
With a current ratio of 2.30, Art's-Way Manufacturing holds $2.30 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 66/100.
Art's-Way Manufacturing's operations used $904K of cash, and capex of $628K added to the outflow, for a free cash flow shortfall of $1.5M. This results in a cash flow score of 22/100.
Art's-Way Manufacturing's ROE of 7.8% shows moderate profitability relative to equity, earning a score of 46/100. This is up from 2.5% the prior year.
Art's-Way Manufacturing scores 3.06, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Art's-Way Manufacturing passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Art's-Way Manufacturing used $0.87 of operating cash (-$904K OCF vs $1.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Art's-Way Manufacturing earns $0.79 in operating income for every $1 of interest expense ($289K vs $367K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Art's-Way Manufacturing generated $7.9M in revenue in Q2 2026. This represents an increase of 23.9% from the same quarter a year earlier. Against the prior quarter it is up 18.3%.
Art's-Way Manufacturing's EBITDA was $492K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 29.8% from the same quarter a year earlier. Against the prior quarter it is down 8.0%.
Art's-Way Manufacturing reported $173K in net income in Q2 2026. This represents a decrease of 88.3% from the same quarter a year earlier. Against the prior quarter it is down 11.7%.
Not reported for Q2 2026.
Cash & Balance Sheet
Art's-Way Manufacturing generated $21K in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 98.3% from the same quarter a year earlier. Against the prior quarter it is up 176.3%.
Art's-Way Manufacturing held $6K in cash against $2.2M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Art's-Way Manufacturing's gross margin was 25.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 6.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.9 percentage points.
Art's-Way Manufacturing's operating margin was 3.6% in Q2 2026, reflecting core business profitability. This is down 4.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.3 percentage points.
Art's-Way Manufacturing's net profit margin was 2.2% in Q2 2026, showing the share of revenue converted to profit. This is down 21.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.
Art's-Way Manufacturing's ROE was 1.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 9.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.
Capital Allocation
Art's-Way Manufacturing spent $2K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding.
Art's-Way Manufacturing invested $341K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 160.6% from the same quarter a year earlier. Against the prior quarter it is up 93.1%.
Not reported for Q2 2026.
ARTW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.9M+23.9% | $6.6M+29.2% | $5.1M-17.9% | $6.4M+9.5% | $6.3M-5.8% | $5.1M-10.2% | $6.2M-10.0% | $5.9M-27.6% |
| Cost of Revenue | $5.8M+36.1% | $4.7M+29.8% | $4.1M+4.6% | $4.7M+11.7% | $4.3M-11.3% | $3.6M-14.2% | $3.9M-20.2% | $4.2M-28.2% |
| Gross Profit | $2.0M-1.4% | $1.9M+27.7% | $944K-57.6% | $1.8M+3.9% | $2.1M+8.0% | $1.5M+1.6% | $2.2M+16.6% | $1.7M-26.1% |
| SG&A Expenses | $1.2M+18.3% | $1.0M-1.9% | $1.1M-8.8% | $983K-9.5% | $1.0M-16.6% | $1.1M-14.0% | $1.2M+7.6% | $1.1M-0.8% |
| Operating Income | $287K-43.9% | $330K+13180.4% | -$568K-209.7% | $345K+124.3% | $511K+202.6% | $2K+100.7% | $518K+498.7% | $154K-67.2% |
| EBITDA | $492K-29.8% | $535K+153.9% | -$370K-151.2% | $541K+41.1% | $701K+77.4% | $211K+222.4% | $722K+176.0% | $383K-41.9% |
| Interest Expense | $113K+13.4% | $111K+46.4% | $108K-13.2% | $84K-44.2% | $100K-37.6% | $76K-54.3% | $124K-19.7% | $150K-6.7% |
| Income Tax | $52K-86.7% | $59K+502.7% | -$44K-158.8% | $67K+2575.0% | $394K+64343.2% | -$15K+87.0% | $75K-7.2% | -$3K-104.2% |
| Net Income | $173K-88.3% | $196K+452.3% | -$646K-177.6% | $254K+1069.9% | $1.5M+4545.3% | -$56K+88.0% | $832K+370.2% | -$26K+64.6% |
| EPS (Basic) | $0.03-89.7% | $0.04+500.0% | -$0.13-181.3% | $0.05+600.0% | $0.29+3000.0% | -$0.01+88.9% | $0.16+366.7% | -$0.010.0% |
| EPS (Diluted) | N/A | $0.04+500.0% | -$0.13-181.3% | $0.05 | $0.29 | -$0.01+88.9% | $0.16+366.7% | -$0.01 |
| Diluted Shares (Avg) | N/A | 5M+1.7% | N/A | 5M | 5M | 5M+0.6% | N/A | 5M |
Not reported in any period shown, so not listed: R&D Expenses.
ARTW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $23.7M+13.4% | $24.6M+16.9% | $22.5M+5.8% | $21.8M-7.1% | $20.9M-9.9% | $21.0M-13.4% | $21.2M-13.0% | $23.5M-8.2% |
| Current Assets | $16.0M+20.6% | $17.0M+30.4% | $14.8M+12.6% | $14.2M+0.9% | $13.3M-2.5% | $13.0M-11.6% | $13.1M-13.0% | $14.0M-13.9% |
| Cash & Equivalents | $6K+31.6% | $3K-28.9% | $5K+160.7% | $6K+16.4% | $5K+1.0% | $4K+66.3% | $2K-53.7% | $5K+21.4% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $11.5M+6.7% | $12.1M+10.9% | $11.7M+13.4% | $11.2M+5.1% | $10.8M+2.7% | $10.9M-0.9% | $10.3M-6.4% | $10.7M-1.3% |
| Accounts Receivable | $2.7M+47.0% | $3.4M+144.0% | $2.2M-7.2% | $2.0M-31.2% | $1.8M-30.5% | $1.4M-53.8% | $2.4M-30.9% | $2.9M-33.9% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $9.9M+36.1% | $11.0M+23.5% | $9.2M+0.3% | $7.9M-35.3% | $7.3M-39.2% | $8.9M-31.6% | $9.1M-28.3% | $12.2M-10.8% |
| Current Liabilities | $7.4M+51.4% | $8.4M+29.1% | $6.4M-2.9% | $5.6M-38.4% | $4.9M-44.0% | $6.5M-33.2% | $6.6M-29.4% | $9.1M-11.2% |
| Non-Current Liabilities | $2.5M+4.6% | $2.6M+8.4% | $2.7M+8.7% | $2.3M-26.2% | $2.4M-26.4% | $2.4M-26.8% | $2.5M-25.3% | $3.1M-9.5% |
| Long-Term Debt | $2.2M-4.7% | $2.3M-1.8% | $2.3M+17.7% | $1.9M-26.1% | $2.3M-9.6% | $2.3M+17.7% | $2.0M-24.9% | $2.5M-4.3% |
| Total Equity | $13.8M+1.3% | $13.5M+12.1% | $13.3M+10.0% | $13.9M+23.5% | $13.6M+21.3% | $12.1M+7.8% | $12.1M+3.9% | $11.3M-5.2% |
| Retained Earnings | $8.7M-0.2% | $8.6M+17.7% | $8.4M+14.1% | $9.0M+38.7% | $8.8M+34.2% | $7.3M+10.9% | $7.3M+4.4% | $6.5M-11.4% |
Not reported in any period shown, so not listed: Goodwill.
ARTW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $362K-73.3% | $148K+245.8% | -$889K-174.3% | -$1.3M-548.8% | $1.4M+8.6% | -$102K-2.5% | $1.2M+158.2% | $282K+169.4% |
| Depreciation & Amortization | $205K+8.0% | $205K-1.7% | $198K-2.9% | $196K-14.6% | $190K-16.1% | $208K0.0% | $204K+16.5% | $230K+20.1% |
| Stock-Based Compensation | N/A | $43K-2.9% | N/A | N/A | N/A | $44K-33.0% | N/A | N/A |
| Capital Expenditures | $341K+160.6% | $176K+113.2% | $153K+38.6% | $261K+156.7% | $131K-43.5% | $83K-70.6% | $110K-59.5% | $102K+87.4% |
| Free Cash Flow | $21K-98.3% | -$28K+84.8% | -$1.0M-195.9% | -$1.5M-946.7% | $1.2M+20.5% | -$185K+51.5% | $1.1M+468.5% | $181K+257.6% |
| Investing Cash Flow | -$258K-97.7% | -$172K-108.3% | -$115K-107.3% | -$252K-149.7% | -$131K+43.5% | -$83K+70.6% | $1.6M+726.2% | -$101K-166.9% |
| Financing Cash Flow | -$101K+91.8% | $22K-88.2% | $1.0M+136.1% | $1.5M+941.7% | -$1.2M-20.7% | $187K-50.7% | -$2.8M-1207.7% | -$181K+28.8% |
| Share Buybacks | $2K | $0-100.0% | $0 | $0 | $0 | $2K-95.9% | $0-100.0% | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
ARTW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 25.9%-6.6pp | 28.8%-0.3pp | 18.6%-17.5pp | 27.5%-1.5pp | 32.5%+4.2pp | 29.1%+3.4pp | 36.1%+8.2pp | 28.9%+0.6pp |
| Operating Margin | 3.6%-4.4pp | 5.0%+4.9pp | -11.2%-19.6pp | 5.4%+2.7pp | 8.1%+5.6pp | 0.1%+6.7pp | 8.4%+7.1pp | 2.6%-3.1pp |
| Net Margin | 2.2%-21.2pp | 3.0%+4.0pp | -12.7%-26.2pp | 4.0%+4.4pp | 23.4%+23.9pp | -1.1%+7.0pp | 13.5%+18.0pp | -0.4%+0.5pp |
| Return on Equity | 1.3%-9.6pp | 1.5%+1.9pp | -4.9%-11.7pp | 1.8%+2.1pp | 10.9%+11.2pp | -0.5%+3.7pp | 6.9%+9.5pp | -0.2%+0.4pp |
| Return on Assets | 0.7%-6.4pp | 0.8%+1.1pp | -2.9%-6.8pp | 1.2%+1.3pp | 7.1%+7.2pp | -0.3%+1.6pp | 3.9%+5.2pp | -0.1%+0.2pp |
| Current Ratio | 2.17-0.6x | 2.020.0x | 2.30+0.3x | 2.54+1.0x | 2.72+1.2x | 2.00+0.5x | 1.98+0.4x | 1.550.0x |
| Debt-to-Equity | 0.160.0x | 0.170.0x | 0.170.0x | 0.14-0.1x | 0.17-0.1x | 0.190.0x | 0.16-0.1x | 0.230.0x |
| Asset Turnover | 0.330.0x | 0.270.0x | 0.23-0.1x | 0.290.0x | 0.300.0x | 0.240.0x | 0.290.0x | 0.25-0.1x |
| FCF Margin | 0.3%-19.0pp | -0.4%+3.2pp | -20.6%-38.2pp | -23.8%-26.8pp | 19.3%+4.2pp | -3.6%+3.1pp | 17.6%+14.8pp | 3.1%+2.5pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Art's-Way Manufacturing ARTW | FY2025 | $23.0M | $1.0M | 4.5% | $15.8M | 36/100 |
| Hydrofarm Holdings Group, Inc. HYFM | FY2025 | $134.3M | -$289.8M | N/A | $4.9M | 23/100 |
| Xos Inc XOS | FY2025 | $46.0M | -$25 | 0.0% | $42.9M | 54/100 |
| GreenPower Mtr Co Inc GP | FY2024 | $39.3M | -$18.3M | -46.7% | $8.0M | — |
| Huachen AI Parking Management Technology Holding Co. HCAI | FY2025 | $6.6M | -$42.2M | N/A | $37.1M | 22/100 |
| Urban-Gro, Inc. UGRO | FY2025 | N/A | N/A | N/A | $4.9M | — |
Where Art's-Way Manufacturing Ranks
Frequently Asked Questions
What is Art's-Way Manufacturing's annual revenue?
Art's-Way Manufacturing (ARTW) reported $23.0M in total revenue for fiscal year 2025. This represents a -6.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Art's-Way Manufacturing's revenue growing?
Art's-Way Manufacturing (ARTW) revenue declined by 6.2% year-over-year, from $24.5M to $23.0M in fiscal year 2025.
Is Art's-Way Manufacturing profitable?
Yes, Art's-Way Manufacturing (ARTW) reported a net income of $1.0M in fiscal year 2025, with a net profit margin of 4.5%.
What is Art's-Way Manufacturing's EBITDA?
Art's-Way Manufacturing (ARTW) had EBITDA of $1.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Art's-Way Manufacturing have?
As of fiscal year 2025, Art's-Way Manufacturing (ARTW) had $5K in cash and equivalents against $2.3M in long-term debt.
What is Art's-Way Manufacturing's gross margin?
Art's-Way Manufacturing (ARTW) had a gross margin of 27.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Art's-Way Manufacturing's operating margin?
Art's-Way Manufacturing (ARTW) had an operating margin of 1.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Art's-Way Manufacturing's net profit margin?
Art's-Way Manufacturing (ARTW) had a net profit margin of 4.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Art's-Way Manufacturing's return on equity (ROE)?
Art's-Way Manufacturing (ARTW) has a return on equity of 7.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Art's-Way Manufacturing's free cash flow?
Art's-Way Manufacturing (ARTW) recorded an outflow of $1.5M in free cash flow during fiscal year 2025. This represents a -180.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Art's-Way Manufacturing's operating cash flow?
Art's-Way Manufacturing (ARTW) recorded an outflow of $904K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Art's-Way Manufacturing's total assets?
Art's-Way Manufacturing (ARTW) had $22.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Art's-Way Manufacturing's capital expenditures?
Art's-Way Manufacturing (ARTW) invested $628K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Art's-Way Manufacturing spend on research and development?
Art's-Way Manufacturing (ARTW) invested $228K in research and development during fiscal year 2025.
What is Art's-Way Manufacturing's current ratio?
Art's-Way Manufacturing (ARTW) had a current ratio of 2.30 as of fiscal year 2025, which is generally considered healthy.
What is Art's-Way Manufacturing's debt-to-equity ratio?
Art's-Way Manufacturing (ARTW) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Art's-Way Manufacturing's return on assets (ROA)?
Art's-Way Manufacturing (ARTW) had a return on assets of 4.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Art's-Way Manufacturing's P/E ratio?
Art's-Way Manufacturing (ARTW) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to May 31, 2026). The market capitalization is $15.8M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Art's-Way Manufacturing's price-to-sales ratio?
Art's-Way Manufacturing (ARTW) trades at 0.6x sales, its market capitalization divided by revenue of $26.0M revenue, trailing 12 months to May 31, 2026. The market capitalization is $15.8M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Art's-Way Manufacturing's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Art's-Way Manufacturing (ARTW) held $5K in cash, cash equivalents and investments, and reported an operating cash outflow of $904K over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Art's-Way Manufacturing's Altman Z-Score?
Art's-Way Manufacturing (ARTW) has an Altman Z-Score of 3.06, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Art's-Way Manufacturing's Piotroski F-Score?
Art's-Way Manufacturing (ARTW) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Art's-Way Manufacturing's earnings high quality?
For every $1 of reported earnings, Art's-Way Manufacturing (ARTW) used $0.87 of operating cash (-$904K OCF vs $1.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Art's-Way Manufacturing cover its interest payments?
Art's-Way Manufacturing (ARTW) has an interest coverage ratio of 0.79x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Art's-Way Manufacturing?
Art's-Way Manufacturing (ARTW) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.